MR1 and cancer: MR1 molecules produced by bacteria-infected cells and cancer cells attract T-cell receptors on the T-cell surface in humans, [12] and research has shown that surface expression of MR1 on cancer cells is recognized by MR1-T cell clones in most human cancer types and could be a promising target of cancer immunotherapy [13].